Circulating immune complexes and monocyte Fc function in autoimmune diseases.

Area of Science:

• Immunology
• Cell Biology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
• Monocyte dysfunction, including impaired phagocytosis, is implicated in SLE pathogenesis.
• Elevated immune complexes are a hallmark of SLE and contribute to disease activity.

Purpose of the Study:

• To investigate the phagocytic capacity of monocytes in SLE patients.
• To explore the relationship between monocyte reactivity, immune complex levels, and SLE.
• To evaluate the effect of levamisole treatment on monocyte function and immune complex levels in SLE.

Main Methods:

• Assessed phagocytosis of latex particles and yeast by monocytes from SLE patients and healthy controls.
• Measured the reactivity of SLE monocytes with antibody-coated sheep red blood cells.
• Correlated monocyte reactivity with serum immune complex levels.
• Evaluated changes in phagocytic function and immune complex levels after levamisole treatment.

Main Results:

• Monocytes from SLE patients exhibited subnormal phagocytosis of latex and yeast compared to controls.
• SLE monocytes showed significantly higher reactivity towards antibody-coated sheep red blood cells.
• A positive correlation was observed between the percentage of reactive monocytes and serum immune complex levels.
• Levamisole treatment restored monocyte phagocytic function and decreased circulating immune complexes.

Conclusions:

• Monocyte phagocytosis is impaired in SLE patients, but specific reactivity is enhanced.
• Immune complex levels are linked to monocyte dysfunction in SLE.
• Levamisole demonstrates potential in restoring monocyte function and reducing immune complexes in SLE.